Summary：**Khyber Pakhtunkhwa rolls out life‑saving HPV vaccine for 2.9 million girls****Introduction** The

**Khyber Pakhtunkhwa rolls out life‑saving HPV vaccine for 2.9 million girls**

**Introduction**
The provincial government of Khyber Pakhtunkhwa (KP) has launched a massive immunization drive targeting 2.9 million adolescent girls with the human papillomavirus (HPV) vaccine. Announced on Monday, the campaign aims to curb cervical cancer, a leading cause of female mortality in Pakistan. Health officials say the rollout is the largest single‑phase HPV initiative ever undertaken in the country, positioning KP as a pioneer in preventive women’s health.

**Key Developments**
Over the next six months, mobile vaccination teams will visit schools, community centres and hard‑to‑reach villages across all 26 districts. The vaccine, administered in two doses six months apart, protects against HPV strains 16 and 18, responsible for roughly 70 % of cervical cancer cases. To boost uptake, the department has partnered with local NGOs, religious leaders and school administrators to dispel myths and provide culturally sensitive information. A real‑time digital dashboard will track coverage rates, adverse events and supply chain logistics, ensuring transparency and rapid response to any gaps.

**Industry Analysis**
Public health experts view the KP campaign as a test case for scaling HPV immunization in low‑resource settings. While Pakistan’s national immunization program has struggled with vaccine hesitancy and supply constraints, KP’s approach—combining school‑based delivery, community engagement and robust monitoring—mirrors successful models from Rwanda and Bhutan. Economically, preventing cervical cancer reduces long‑term treatment costs, which the World Health Organization estimates could save the Pakistani health system upwards of US$150 million annually if coverage reaches 80 % nationwide. Challenges remain, including cold‑chain maintenance in remote areas and securing sustainable financing beyond the initial donor‑supported phase.

**Future Outlook